StartseiteMCPWorkbenchSkills
StartseiteWorkbenchBenachrichtigungenMein Bereich
llms.txt · MCP-AnleitungDatenschutz · Nutzungsbedingungen · Supportv1.8.3
  1. Startseite
  2. /Verbindung

Fludrocortison-21-acetat

Fludrocortisone Acetate

HCID 225609
Neue Reaktion
Drucken
GrundinformationenÜberblickNamen und BezeichnerEigenschaftenSicherheit und RegulatorischesChemie und IndustrieZugehörige ReaktionenNotizen zur Verbindung
TeilstruktursucheÄhnliche Strukturen suchen

Grundinformationen

CAS
514-36-3
Standard-SMILES
CC(=O)OCC(=O)[C@@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@@]3(F)[C@@H](O)C[C@@]21C
InChIKey
SYWHXTATXSMDSB-GSLJADNHSA-N
Summenformel
C23H31FO6
Durchschnittliche Molmasse
422,5 g/mol
Monoisotopische Masse
422,21046687

Überblick

Fludrocortisone acetate is an acetate ester resulting from the formal condensation of the primary hydroxy group of fludrocortisone with acetic acid. A synthetic corticosteroid, it has glucocorticoid actions about 10 times as potent as hydrocortisone, while its mineralocorticoid actions are over 100 times as potent. It is used in partial replacement therapy for primary and secondary adrenocortical insufficiency in Addison's disease and for the treatment of salt-losing adrenal hyperplasia. It is a tertiary alpha-hydroxy ketone, a mineralocorticoid, a 17alpha-hydroxy steroid, an 11beta-hydroxy steroid, a 20-oxo steroid, an acetate ester, a 3-oxo-Delta(4) steroid and a fluorinated steroid. It is functionally related to a fludrocortisone.

Namen und Bezeichner

Bevorzugter Name
Fludrocortisone Acetate
IUPAC
[2-[(8S,9R,10S,11S,13S,14S,17R)-9-fluoro-11,17-dihydroxy-10,13-dimethyl-3-oxo-1,2,6,7,8,11,12,14,15,16-decahydrocyclopenta[a]phenanthren-17-yl]-2-oxoethyl] acetate
Lokaler Name
Fludrocortison-21-acetat
Englischer Name
Fludrocortisone acetate
Summenformel
C23H31FO6
Molmasse
422.49

Namen und Synonyme

FLUDROCORTISONE ACETATE514-36-3ScherofluronAlflorone acetateFlorinef acetateFludrocortisone 21-acetateCortef-FFluorocortisol acetateFluorocortisone acetateFluohydrocortisone acetate9alpha-Fluorohydrocortisone acetate9alpha-Fluorohydrocortisone 21-acetate
Weitere Namen anzeigen
9-FLUOROHYDROCORTISONE ACETATE9αNSC 15186cortineffalfloroneacetate9-FLUOROCORTISOL ACETATE
V47IF0PVH4U 4845NSC-15186Fludrocortisoni acetasDTXSID20230629-Fluoro-11beta,17,21-trihydroxypregn-4-ene-3,20-dione 21-acetateCHEBI:5102NSC15186

Datenbank-Bezeichner

CAS
514-36-3
PubChem CID
225609
DTXSID
DTXSID2023062

Eigenschaften

Berechnete Struktureigenschaften

XLogP
1,7
Polarare Oberfläche (TPSA)
101 Ų
H-Brücken-Donoren
2
H-Brücken-Akzeptoren
7
Frei drehbare Bindungen
4
Schwere Atome
30
Formalladung
0
Komplexität
838

Experimentelle und physikochemische Eigenschaften

DrugsPharmaceuticals -> Dermatologicals -> Corticosteroids, dermatological preparations
LipidsLipids -> Sterol Lipids [ST] -> Steroids [ST02] -> C21 steroids (gluco/mineralocorticoids, progestogins) and derivatives [ST0203]
Human Drugs · 2 Einträge

FDA approved drugs -> Active ingredient

FDA approved drugs -> Active ingredient

Collision Cross Section189.7 Ų [M+H]+ [CCS Type: TW; Method: calibrated with polyalanine and drug standards]

Physikochemische Eigenschaften

Schmelzpunkt
233 · 233-234°C
Siedepunkt
575.1 · 575.1±50.0 °C(Predicted)
Dichte
1.0953 · 1.0953 (rough estimate)
Brechungsindex
1.598 · 1.5980 (estimate)
storage temp.
2 · 2-8°C
Löslichkeit
Practically insoluble in water, sparingly soluble in anhydrous ethanol.

Sicherheit und Regulatorisches

Sicherheitsangaben dienen nur zur Orientierung und ersetzen weder das Sicherheitsdatenblatt (SDB) des Lieferanten noch geltende Vorschriften oder eine fachliche Bewertung.

GHS-Klassifizierung

GHS Classification · 4 Einträge

Warning

H302 (95.2%): Harmful if swallowed [Warning Acute toxicity, oral]

P203, P264, P270, P280, P301+P317, P318, P330, P405, and P501 (click each P-code to see the statement)

Aggregated GHS information provided per 42 reports by companies from 5 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.

Gefahrenhinweise

Other Safety InformationIMAP assessments - Pregn-4-ene-3,20-dione, 21-(acetyloxy)-9-fluoro-11,17-dihydroxy-, (11.beta.)-: Environment tier I assessment
Hazard Classes and CategoriesAcute Tox. 4 (95.2%)

Toxikologische Informationen

Drug Induced Liver Injury · 6 Einträge

Drug Induced Liver Injury Rank (DILIrank 2.0)

Fludrocortisone acetate

vNo-DILI-concern

0

No match

DOI:10.1016/j.drudis.2016.02.015

EPA Human Health Benchmarks for Pharmaceuticals · 6 Einträge

Fludrocortisone acetate

0.001

0.004

The usual dose is 0.1 mg of fludrocortisone acetate tablets daily, although dosage ranging from 0.1 mg three times a week to 0.2 mg daily has been employed. In the event transient hypertension develops as a consequence of therapy, the dose should be reduced to 0.05 mg daily.

Data used to generate the benchmarks include the following: Lowest Daily Dose (LDD): 0.043 mg/day, Lowest Therapeutic Dose (LTD): 0.0005 mg/kg-day, and Screening Dose: 0.0000002 mg/kg-day.

Chemie und Industrie

Anwendungen · 1 Eintrag

BeschreibungFludrocortisone acetate is the acetate form of the synthetic corticosteroid fludrocortisone, which is a mineralocorticoid receptor agonist. Fludrocortisone acetate (0.1-5 μg/animal) promotes sodium retention in rats in a dose-dependent manner with 37% of sodium excreted compared with control when used at a dose of 5 μg/animal. Formulations containing fludrocortisone acetate have been used in the treatment of Addison’s disease.

Vor- und nachgelagerte Produkte

Vorgelagerte Rohstoffe

Phosphorus oxychloridehydrogen fluoridehypobromous acidHydrocortison-21-acetatFluorwasserstoff9,11-Epoxypregn-4-ene-17,21-diol-3,20-dione 21-acetateDichlormethanPyridine hydrofluoride

Nachgelagerte Produkte

Isoflupredon-21-acetat
Ergänzende Hinweise · 1 Eintrag

DefinitionChEBI: An acetate ester resulting from the formal condensation of the primary hydroxy group of fludrocortisone with acetic acid. A synthetic corticosteroid, it has glucocorticoid actions about 10 times as potent as hydrocortisone, while its mineralocorticoid acti ns are over 100 times as potent. It is used in partial replacement therapy for primary and secondary adrenocortical insufficiency in Addison's disease and for the treatment of salt-losing adrenal hyperplasia.

Zugehörige Reaktionen

1
Reaktionsaufzeichnung erstellen
Reaktionsgleichung von HRID 2197394
HRID 2197394als Edukt

Notizen zur Verbindung

Auf dieser SeiteGrundinformationenÜberblickNamen und BezeichnerEigenschaftenSicherheit und RegulatorischesChemie und IndustrieZugehörige ReaktionenNotizen zur Verbindung
ChEMBL
CHEMBL1201010
ChEBI
CHEBI:5102
UNII
V47IF0PVH4
EC Number
208-180-4
Nikkaji
J6.287A
pka
12.06 · 12.06±0.70(Predicted)
Aggregatzustand
Solid
Farbe
White to Off-White
Biologische Quelle
synthetic
Wasserlöslichkeit
54 mg/L · 54mg/L(25 ºC)
InChIKey
UUHYILPJUKGJDI-XYNXPQAZSA-N
SMILES
F[C@]12[C@H](C[C@@]3([C@@](O)(C(=O)COC(=O)C)CC[C@@]3([H])[C@]1([H])CCC1=CC(=O)CC[C@]21C)C)O |&1:1,2,4,5,16,18,28,r|
CAS Datenbank
514 · 514-36-3(CAS DataBase Reference)
EPA chemische Informationen
Fluorocortisone acetate (514-36-3)

18-May-21

Sicherheitsdaten

wgk
3
hs_code
2937220000
RTECS-Nr.
TU5050000
risk_code
63
Toxizität
LD50 oral in rat: > 1gm/kg
hazard_code
Xn
safety_code
22-26-36
Speicherklasse
11 - Combustible Solids
Hazard Classifications
Acute Tox. 4 OralRepr. 2